ATE186464T1 - Zusammensetzungen und verfahren zur regulierung der rns-aktivität durch abänderung der rns ''5'- cap-struktur'' - Google Patents

Zusammensetzungen und verfahren zur regulierung der rns-aktivität durch abänderung der rns ''5'- cap-struktur''

Info

Publication number
ATE186464T1
ATE186464T1 AT91911934T AT91911934T ATE186464T1 AT E186464 T1 ATE186464 T1 AT E186464T1 AT 91911934 T AT91911934 T AT 91911934T AT 91911934 T AT91911934 T AT 91911934T AT E186464 T1 ATE186464 T1 AT E186464T1
Authority
AT
Austria
Prior art keywords
rns
cap structure
methods
regulating
altering
Prior art date
Application number
AT91911934T
Other languages
English (en)
Inventor
Brenda F Baker
Original Assignee
Isis Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Isis Pharmaceuticals Inc filed Critical Isis Pharmaceuticals Inc
Application granted granted Critical
Publication of ATE186464T1 publication Critical patent/ATE186464T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C07H21/04Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H23/00Compounds containing boron, silicon, or a metal, e.g. chelates, vitamin B12

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT91911934T 1990-05-23 1991-05-22 Zusammensetzungen und verfahren zur regulierung der rns-aktivität durch abänderung der rns ''5'- cap-struktur'' ATE186464T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US52759990A 1990-05-23 1990-05-23

Publications (1)

Publication Number Publication Date
ATE186464T1 true ATE186464T1 (de) 1999-11-15

Family

ID=24102143

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91911934T ATE186464T1 (de) 1990-05-23 1991-05-22 Zusammensetzungen und verfahren zur regulierung der rns-aktivität durch abänderung der rns ''5'- cap-struktur''

Country Status (15)

Country Link
EP (1) EP0531447B1 (de)
JP (1) JPH06500075A (de)
KR (1) KR960004931B1 (de)
AT (1) ATE186464T1 (de)
AU (1) AU649458B2 (de)
BR (1) BR9106486A (de)
CA (1) CA2083377C (de)
DE (1) DE69131773T2 (de)
DK (1) DK0531447T3 (de)
ES (1) ES2139578T3 (de)
FI (1) FI925210A (de)
GR (1) GR3032457T3 (de)
HU (1) HUT63568A (de)
NO (1) NO924309L (de)
WO (1) WO1991017755A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5789573A (en) * 1990-08-14 1998-08-04 Isis Pharmaceuticals, Inc. Antisense inhibition of ICAM-1, E-selectin, and CMV IE1/IE2
EP0691853B1 (de) * 1993-04-01 2002-06-05 Isis Pharmaceuticals, Inc. ANTISENSE OLIGONNUKLEOTIDE DIE MIT DER mRNA CAP AKTIVITÄT INTERFERIEREN UND DIE TRANSLATION INHIBIEREN
IL114235A0 (en) * 1994-07-14 1995-10-31 Schering Ag Oligonucleotide conjugates and processes for noninvasive diagnosis utilizing the same
US6380169B1 (en) * 1994-08-31 2002-04-30 Isis Pharmaceuticals, Inc. Metal complex containing oligonucleoside cleavage compounds and therapies
US5962271A (en) * 1996-01-03 1999-10-05 Cloutech Laboratories, Inc. Methods and compositions for generating full-length cDNA having arbitrary nucleotide sequence at the 3'-end
EP1261734A1 (de) * 2000-02-25 2002-12-04 Montclair Group GENOMISCHE ANALYSE VON tRNA-GENSETS
EP2370451B1 (de) 2008-12-02 2016-11-16 Wave Life Sciences Japan, Inc. Verfahren zur synthese von am phosphoratom modifizierten nukleinsäuren
AU2010270714B2 (en) 2009-07-06 2015-08-13 Wave Life Sciences Ltd. Novel nucleic acid prodrugs and methods use thereof
EP2620428B1 (de) 2010-09-24 2019-05-22 Wave Life Sciences Ltd. Asymmetrische hilfsgruppe
JP6128529B2 (ja) 2011-07-19 2017-05-17 ウェイブ ライフ サイエンシズ リミテッドWave Life Sciences Ltd. 官能化核酸の合成のための方法
US9617547B2 (en) 2012-07-13 2017-04-11 Shin Nippon Biomedical Laboratories, Ltd. Chiral nucleic acid adjuvant
CN104661664B (zh) 2012-07-13 2020-07-03 波涛生命科学有限公司 手性控制
EP2872485B1 (de) 2012-07-13 2020-12-16 Wave Life Sciences Ltd. Asymmetrische hilfsgruppe
US10322173B2 (en) 2014-01-15 2019-06-18 Shin Nippon Biomedical Laboratories, Ltd. Chiral nucleic acid adjuvant having anti-allergic activity, and anti-allergic agent
WO2015108048A1 (ja) 2014-01-15 2015-07-23 株式会社新日本科学 抗腫瘍作用を有するキラル核酸アジュバンド及び抗腫瘍剤
JPWO2015108047A1 (ja) 2014-01-15 2017-03-23 株式会社新日本科学 免疫誘導活性を有するキラル核酸アジュバンド及び免疫誘導活性剤
CA2936712A1 (en) 2014-01-16 2015-07-23 Meena Chiral design

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4806463A (en) * 1986-05-23 1989-02-21 Worcester Foundation For Experimental Biology Inhibition of HTLV-III by exogenous oligonucleotides
HUT63170A (en) * 1990-01-11 1993-07-28 Isis Pharmaceuticals Inc Process and composition for detecting and modifying rna activity and gene expression

Also Published As

Publication number Publication date
CA2083377C (en) 2002-11-26
KR930700118A (ko) 1993-03-13
EP0531447A4 (en) 1993-08-11
EP0531447A1 (de) 1993-03-17
HU9203659D0 (en) 1993-04-28
DE69131773D1 (de) 1999-12-16
AU8080291A (en) 1991-12-10
FI925210A0 (fi) 1992-11-17
BR9106486A (pt) 1993-05-25
JPH06500075A (ja) 1994-01-06
NO924309D0 (no) 1992-11-09
AU649458B2 (en) 1994-05-26
KR960004931B1 (ko) 1996-04-18
ES2139578T3 (es) 2000-02-16
GR3032457T3 (en) 2000-05-31
HUT63568A (en) 1993-09-28
NO924309L (no) 1992-11-09
DK0531447T3 (da) 2000-03-27
EP0531447B1 (de) 1999-11-10
CA2083377A1 (en) 1991-11-24
FI925210A (fi) 1992-11-17
WO1991017755A1 (en) 1991-11-28
DE69131773T2 (de) 2000-03-02

Similar Documents

Publication Publication Date Title
ATE186464T1 (de) Zusammensetzungen und verfahren zur regulierung der rns-aktivität durch abänderung der rns ''5'- cap-struktur''
DE3280400D1 (de) Oligonukleotides heilmittel und dessen herstellungsverfahren.
BR9106751A (pt) Oligonucleotideo ou analogo de nucleotideo e processo para modulacao da atividade de uma infeccao por citomegalovirus
IT8619684A0 (it) Preparato di acido ialuronico chimicamente modificato e metodo per recuperarlo da tessuti animali.
DE69433626D1 (de) N-2 substituierte purine
PL334530A1 (en) Novel genes specific in respect to n-axecetyl-l-phosphotricin, used to code amino acids deacetylase, their isolation and application
ATE292141T1 (de) Oligoribonukleotide und ribonucleasen zur spaltung von rns
MX9602993A (es) Hormona del crecimiento humano.
PT1053313E (pt) Oligonucleotidos ''antisense'' optimizados complementares de sequencias de dna metiltransferase
DE69729145D1 (de) Reagenz und Verfahren zur Inhibierung der N-RAS Expression
ATE342067T1 (de) Verfahren zur behandlung von vaskulären proliferativen erkrankungen mit p27 und fusionen davon
DE69032080T2 (de) Verwendung von konservierten Oligonukleotid-Primern zur Amplifizierung von menschlichen Papillomavirus-DNS-Sequenzen
ATE264913T1 (de) Protease-resistente analoge des thrombomodulin
KR950700079A (ko) 이식체-대-숙주 질환을 억제하기 위한 인터루킨-10의 용도(Use of interleukin-10 to suppress graft-vs. -host disease)
DE69833876D1 (de) Zusammensetzungen und methoden zur zielgerichteten abgabe von biologisch aktivenfaktoren
DE19681032D2 (de) Gentherapeutisches Nukleinsäurekonstrukt, seine Herstellung und Verwendung zur Behandlung von Herzerkrankungen
MX9703188A (es) Acidos nucleicos de aminoacido.
ATE218372T1 (de) Antisense oligonnukleotide die mit der mrna cap aktivität interferieren und die translation inhibieren
EP0592685A4 (de) Planze resistent gegen mindestens zwei viren und dessen preparation.
DE69433996D1 (de) Verwendung pharmazeutischer zusammensetzungen zur behandlung von neurodegenerativen krankheiten
AU2782989A (en) Dna and rna molecules stabilized by modifications of the 3'-terminal phosphodiester linkage and their use as nucleic acid probes and as therapeutic agents to block the expression of specifically targeted genes
BR8705815A (pt) Processo para controlar o crescimento de microorganismos e processo para controlar doencas ou crescimento de microorganismos indesejados
FR2617403B1 (fr) Procede de preparation de derives des acides nucleiques et procede de preparation d'une composition medicale les contenant
UA10281C2 (uk) Спосіб отримання речовини для лікування захворювань підшлункової залози
HUP0103860A2 (hu) e-Exonukleáz, továbbá ennek előállítása és alkalmazása

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee